Skip to main content
. Author manuscript; available in PMC: 2012 Aug 30.
Published in final edited form as: Arch Phys Med Rehabil. 2011 Mar 2;92(4):646–652. doi: 10.1016/j.apmr.2010.10.039

Table 1.

Health history of breast cancer survivors (N=59)

Treatment Mean (SD) or % of Sample
Age 58.5 (9.7)
BMI (kg/m2) 28.3 (7.2)
Months since diagnosis 20.9 (6.5)
Stage 0 5%
Stage I 29%
Stage II 39%
Stage III 19%
Chemotherapy only (N=17) 29%
Current adjuvant endocrine therapy (N=19)
 SERM use only (N=7) 12%
 Current AI use only (N=12) 20%
Chemotherapy + current SERM or AI use (N=23) 39%

Abbreviations: SERM: Selective estrogen receptor modulator; AI: Aromatase inhibitor